Roy Winston's most recent trade in Pacira BioSciences Inc was a trade of 27,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 14, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 27,500 | 27,500 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 10,950 | 52,306 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 37.86 per share. | 06 Jun 2023 | 1,857 | 41,356 (0%) | 0% | 37.9 | 70,315 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 38.99 per share. | 06 Jun 2023 | 1,779 | 43,213 (0%) | 0% | 39.0 | 69,365 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 55.70 per share. | 03 Aug 2022 | 476 | 44,992 (0%) | 0% | 55.7 | 26,513 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 24,800 | 24,800 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 9,900 | 45,060 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2022 | 6,250 | 0 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.38 per share. | 06 Jun 2022 | 6,250 | 50,607 (0%) | 0% | 34.4 | 214,844 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 61.59 per share. | 06 Jun 2022 | 3,650 | 37,174 (0%) | 0% | 61.6 | 224,804 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 60.55 per share. | 06 Jun 2022 | 3,533 | 40,824 (0%) | 0% | 60.5 | 213,923 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 60.55 per share. | 06 Jun 2022 | 2,535 | 48,072 (0%) | 0% | 60.5 | 153,494 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 61.59 per share. | 06 Jun 2022 | 2,300 | 45,772 (0%) | 0% | 61.6 | 141,657 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 61.37 per share. | 06 Jun 2022 | 2,099 | 44,357 (0%) | 0% | 61.4 | 128,824 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 62.48 per share. | 06 Jun 2022 | 1,891 | 35,283 (0%) | 0% | 62.5 | 118,150 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 62.43 per share. | 06 Jun 2022 | 1,300 | 44,472 (0%) | 0% | 62.4 | 81,159 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 63.69 per share. | 06 Jun 2022 | 123 | 35,160 (0%) | 0% | 63.7 | 7,834 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 63.40 per share. | 06 Jun 2022 | 115 | 44,357 (0%) | 0% | 63.4 | 7,291 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2021 | 10,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.15 per share. | 04 Nov 2021 | 10,000 | 46,456 (0%) | 0% | 48.2 | 481,500 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Roy Winston | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 5,000 | 36,456 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Roy Winston | Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 61.04 per share. | 04 Jun 2021 | 2,276 | 24,035 (0%) | 0% | 61.0 | 138,920 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 70.36 per share. | 31 Mar 2021 | 16,363 | 32,172 (0%) | 0% | 70.4 | 1,151,301 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.37 per share. | 31 Mar 2021 | 13,750 | 48,535 (0%) | 0% | 34.4 | 472,656 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2021 | 13,750 | 6,250 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Roy Winston | Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 71.09 per share. | 31 Mar 2021 | 4,661 | 27,511 (0%) | 0% | 71.1 | 331,350 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 72.12 per share. | 31 Mar 2021 | 1,200 | 26,311 (0%) | 0% | 72.1 | 86,544 | Common Stock |
| Pacira BioSciences Inc | Roy Winston | Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 62.00 per share. | 13 Nov 2020 | 5,000 | 34,785 (0%) | 0% | 62 | 310,000 | Common Stock |